肝移植与新型冠状病毒感染  

Liver transplantation under the COVID-19

作　　者：许瀛[1] 林栋栋[2] Xu Ying;Lin Dongdong(Beijing You an Hospital,Capital Medical University,Beijing 100069,China;Xuanwu Hospital,Capital Medical University,Beijing 100053,China)

机构地区：[1]首都医科大学附属北京佑安医院,北京100069 [2]首都医科大学宣武医院,北京100053

出　　处：《中华肝胆外科杂志》2023年第7期548-552,共5页Chinese Journal of Hepatobiliary Surgery

摘　　要：新型冠状病毒感染(COVID-19)是一种由严重急性呼吸综合征冠状病毒2(SARS-CoV-2)引起的传染性疾病。自2019年以来,该病在世界范围内传播,已成为国际社会关注的公共卫生疫情。2022年,SARS-CoV-2变异株奥密克戎感染达到高峰,给器官捐献和移植带来巨大挑战。器官移植受者具有较高的免疫抑制风险,是感染SARS-CoV-2的高危人群,在COVID-19诊治方面存在特殊性。本文主要就肝移植受者COVID-19相关诊治特点及新冠疫情下的肝移植捐献进展进行综述。Novel coronavirus infection(COVID-19)is an infectious disease caused by severe acute respiratory syndrome coronavirus 2(SARS-CoV-2).Since 2019,the disease has spread worldwide and has become a public health epidemic of international concern.In 2022,the infection of SARS-CoV-2 variant Omicron reached its peak,posing a huge challenge to organ donation and transplantation.Organ transplant recipients have a high risk of immunosuppression and face with high risk of SARS-CoV-2 infection.There are some particularities in the diagnosis and treatment of COVID-19 in organ transplant recipients.This article reviewed the diagnosis and treatment of COVID-19 in liver transplantation recipients,and the progression of liver donation under the COVID-19.

关 键 词：新型冠状病毒 肝移植 器官捐献 

分 类 号：R657.3[医药卫生—外科学] R563.1[医药卫生—临床医学]